Literature DB >> 16937453

Sustained viral response of a case of acute hepatitis C virus infection via needle-stick injury.

Takayuki Kogure1, Yoshiyuki Ueno, Noriatsu Kanno, Koji Fukushima, Yoko Yamagiwa, Futoshi Nagasaki, Eiji Kakazu, Yasunori Matsuda, Osamu Kido, Yu Nakagome, Masashi Ninomiya, Tooru Shimosegawa.   

Abstract

A 29-year-old nurse with a hepatitis C virus (HCV) infection caused by needle-stick injury was treated with interferon-beta starting about one year after the onset of acute hepatitis. The patient developed acute hepatitis C with symptoms of general fatigues, jaundice, and ascites 4 wk after the needle-stick injury. When these symptoms were presented, the patient was pregnant by artificial insemination. She hoped to continue her pregnancy. After delivery, biochemical liver enzyme returned to normal levels. Nevertheless, HCV RNA was positive and the pathological finding indicated a progression to chronicity. The genotype was 1b with low viral load. Daily intravenous injection of interferon-beta at the dosage of six million units was started and continued for eight weeks. HCV was eradicated without severe adverse effects. In acute hepatitis C, delaying therapy is considered to reduce the efficacy but interferon-beta therapy is one of the useful treatments for hepatitis C infection in chronic phase.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16937453      PMCID: PMC4087847          DOI: 10.3748/wjg.v12.i29.4757

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  17 in total

1.  When and how to treat acute hepatitis C?

Authors:  Anna Licata; Danilo Di Bona; Filippo Schepis; Lillian Shahied; Antonio Craxí; Calogero Cammà
Journal:  J Hepatol       Date:  2003-12       Impact factor: 25.083

2.  Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial.

Authors:  Hideyuki Nomura; Suketo Sou; Hironori Tanimoto; Takashi Nagahama; Yoichi Kimura; Jun Hayashi; Hiromi Ishibashi; Seizaburo Kashiwagi
Journal:  Hepatology       Date:  2004-05       Impact factor: 17.425

3.  Resolution of acute hepatitis C after therapy with natural beta interferon.

Authors:  M Omata; O Yokosuka; S Takano; N Kato; K Hosoda; F Imazeki; M Tada; Y Ito; M Ohto
Journal:  Lancet       Date:  1991-10-12       Impact factor: 79.321

4.  Hepatitis C in hospital employees with needlestick injuries.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Nakano; S Furuta; K Nishioka; R H Purcell; H J Alter
Journal:  Ann Intern Med       Date:  1991-09-01       Impact factor: 25.391

5.  High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study.

Authors:  W Vogel; I Graziadei; F Umlauft; C Datz; F Hackl; S Allinger; K Grünewald; J Patsch
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

6.  Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin. Irish Hepatology Research Group.

Authors:  E Kenny-Walsh
Journal:  N Engl J Med       Date:  1999-04-22       Impact factor: 91.245

7.  Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus.

Authors:  K Kiyosawa; T Sodeyama; E Tanaka; Y Gibo; K Yoshizawa; Y Nakano; S Furuta; Y Akahane; K Nishioka; R H Purcell
Journal:  Hepatology       Date:  1990-10       Impact factor: 17.425

Review 8.  Hepatocellular carcinoma: recent trends in Japan.

Authors:  Kendo Kiyosawa; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Amal Gad; Eiji Tanaka
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

9.  Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

Authors:  J Tilman Gerlach; Helmut M Diepolder; Reinhart Zachoval; Norbert H Gruener; Maria-Christina Jung; Axel Ulsenheimer; Winfried W Schraut; C Albrecht Schirren; M Waechtler; M Backmund; Gerd R Pape
Journal:  Gastroenterology       Date:  2003-07       Impact factor: 22.682

10.  Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

Authors:  T Giuberti; M G Marin; C Ferrari; S Marchelli; C Schianchi; A M Degli Antoni; G Pizzocolo; F Fiaccadori
Journal:  J Hepatol       Date:  1994-05       Impact factor: 25.083

View more
  6 in total

Review 1.  Natural interferon-beta treatment for patients with chronic hepatitis C in Japan.

Authors:  Reina Sasaki; Tatsuo Kanda; Shingo Nakamoto; Yuki Haga; Masato Nakamura; Shin Yasui; Xia Jiang; Shuang Wu; Makoto Arai; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-05-18

Review 2.  Hepatitis C virus in pregnancy.

Authors:  Mona R Prasad; Jonathan R Honegger
Journal:  Am J Perinatol       Date:  2013-02-06       Impact factor: 1.862

Review 3.  Hepatitis C and pregnancy.

Authors:  Annarosa Floreani
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

Review 4.  Features of hepatitis C virus infection, current therapies and ongoing clinical trials in ten Asian Pacific countries.

Authors:  Masao Omata; Tatsuo Kanda; Osamu Yokosuka; Darrell Crawford; Mamun Al-Mahtab; Lai Wei; Alaaeldin Ibrahim; George K K Lau; Barjesh C Sharma; Saeed S Hamid; Wan-Long Chuang; A Kadir Dokmeci
Journal:  Hepatol Int       Date:  2015-05-05       Impact factor: 9.029

5.  Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.

Authors:  Kang Yiu Lai; Wing Yiu George Ng; Fan Fanny Cheng
Journal:  Infect Dis Poverty       Date:  2014-11-28       Impact factor: 4.520

6.  Risk Factors for Hepatitis C Virus (HCV) Infection in Areas with a High Prevalence of HCV in the Republic of Korea in 2013.

Authors:  Hae-Sook Sohn; Jang Rak Kim; So Yeon Ryu; Youn-Jae Lee; Myeong Jin Lee; Hyun Ju Min; Jun Lee; Hwa Young Choi; Yeong Jun Song; Moran Ki
Journal:  Gut Liver       Date:  2016-01       Impact factor: 4.519

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.